Alkaloid AD Logo

Alkaloid AD

Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.

ALK | MSE

Overview

Corporate Details

ISIN(s):
MKALKA101011
LEI:
Country:
North Macedonia
Address:
Blvd. Aleksandar Makedonski 12, 1000 Skopje
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alkaloid AD is a pharmaceutical company with over eight decades of experience in the manufacturing of drugs, cosmetics, and chemical products, as well as the processing of botanical raw materials. The company's operations are structured into two primary profit centers: Pharmacy, and Chemistry, Cosmetics, and Herbal Medicine. Its product portfolio encompasses a wide range of generic drugs, with a focus on oral solid dosage forms, alongside various cosmetic and herbal products. The company also engages in pharmaceutical innovation, holding an international patent for a value-added medicine, liquid Omeprazole. Alkaloid AD serves both healthcare professionals and the general consumer market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alkaloid AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alkaloid AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan 4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden CINPHA
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway CRNA
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.